Bausch Health Companies Inc [NYSE: BHC] slipped around -0.01 points on Thursday, while shares priced at $7.46 at the close of the session, down -0.13%.
Compared to the average trading volume of 2.11M shares, BHC reached a trading volume of 8089282 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Bausch Health Companies Inc [BHC]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BHC shares is $9.26 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BHC stock is a recommendation set at 2.83. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Piper Sandler have made an estimate for Bausch Health Companies Inc shares, keeping their opinion on the stock as Underweight, with their previous recommendation back on August 02, 2024. While these analysts kept the previous recommendation, Raymond James raised their target price to Mkt Perform. The new note on the price target was released on July 10, 2024, representing the official price target for Bausch Health Companies Inc stock. Previously, the target price had yet another raise from $9 to $16, while Jefferies kept a Buy rating on BHC stock.
The Average True Range (ATR) for Bausch Health Companies Inc is set at 0.28, with the Price to Sales ratio for BHC stock in the period of the last 12 months amounting to 0.29. Price to Free Cash Flow for BHC in the course of the last twelve months was 2.64 with Quick ratio for the last quarter at 0.82.
How has BHC stock performed recently?
Bausch Health Companies Inc [BHC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -4.48. With this latest performance, BHC shares dropped by -2.48% in over the last four-week period, additionally plugging by 25.17% over the last 6 months – not to mention a drop of -10.44% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BHC stock in for the last two-week period is set at 42.54, with the RSI for the last a single of trading hit 40.12, and the three-weeks RSI is set at 43.96 for Bausch Health Companies Inc [BHC]. The present Moving Average for the last 50 days of trading for this stock 7.82, while it was recorded at 7.60 for the last single week of trading, and 7.38 for the last 200 days.
Bausch Health Companies Inc [BHC]: Deeper insight into the fundamentals
Bausch Health Companies Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.82 and a Current Ratio set at 1.19.
Earnings analysis for Bausch Health Companies Inc [BHC]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BHC. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Bausch Health Companies Inc go to 11.94%.
Insider trade positions for Bausch Health Companies Inc [BHC]
There are presently around $73.72%, or 83.07%% of BHC stock, in the hands of institutional investors. The top three institutional holders of BHC stocks are: ICAHN CARL C with ownership of 34.72 million shares, which is approximately 9.466%. PAULSON & CO. INC., holding 26.44 million shares of the stock with an approximate value of $$184.28 million in BHC stocks shares; and PAULSON & CO. INC., currently with $$156.39 million in BHC stock with ownership which is approximately 6.117%.
